344 related articles for article (PubMed ID: 11899079)
1. Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.
Takeuchi M; Makita Z
Curr Mol Med; 2001 Jul; 1(3):305-15. PubMed ID: 11899079
[TBL] [Abstract][Full Text] [Related]
2. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
3. Immunological detection of a novel advanced glycation end-product.
Takeuchi M; Yanase Y; Matsuura N; Yamagishi Si S; Kameda Y; Bucala R; Makita Z
Mol Med; 2001 Nov; 7(11):783-91. PubMed ID: 11788793
[TBL] [Abstract][Full Text] [Related]
4. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
5. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
6. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.
Takeuchi M; Makita Z; Yanagisawa K; Kameda Y; Koike T
Mol Med; 1999 Jun; 5(6):393-405. PubMed ID: 10415164
[TBL] [Abstract][Full Text] [Related]
7. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of advanced glycation end products in human cataractous lenses.
Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity of advanced glycation end-products for cultured cortical neurons.
Takeuchi M; Bucala R; Suzuki T; Ohkubo T; Yamazaki M; Koike T; Kameda Y; Makita Z
J Neuropathol Exp Neurol; 2000 Dec; 59(12):1094-105. PubMed ID: 11138929
[TBL] [Abstract][Full Text] [Related]
10. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin.
Ahmed N; Argirov OK; Minhas HS; Cordeiro CA; Thornalley PJ
Biochem J; 2002 May; 364(Pt 1):1-14. PubMed ID: 11988070
[TBL] [Abstract][Full Text] [Related]
11. Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease.
Takeuchi M; Kikuchi S; Sasaki N; Suzuki T; Watai T; Iwaki M; Bucala R; Yamagishi S
Curr Alzheimer Res; 2004 Feb; 1(1):39-46. PubMed ID: 15975084
[TBL] [Abstract][Full Text] [Related]
12. Structure of advanced Maillard reaction products and their pathological role.
Monnier VM; Nagaraj RH; Portero-Otin M; Glomb M; Elgawish AH; Sell DR; Friedlander MA
Nephrol Dial Transplant; 1996; 11 Suppl 5():20-6. PubMed ID: 9044302
[TBL] [Abstract][Full Text] [Related]
13. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical Changes Induced in the Serum Proteins Immunoglobulin G and Fibrinogen Mediated by Methylglyoxal.
Rehman S; Faisal M; Alatar AA; Ahmad S
Curr Protein Pept Sci; 2020; 21(9):916-923. PubMed ID: 31244422
[TBL] [Abstract][Full Text] [Related]
15. Chemical Synthesis of Peptides Containing Site-Specific Advanced Glycation Endproducts.
Kaur H; Kamalov M; Brimble MA
Acc Chem Res; 2016 Oct; 49(10):2199-2208. PubMed ID: 27672697
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
Shibayama R; Araki N; Nagai R; Horiuchi S
Diabetes; 1999 Sep; 48(9):1842-9. PubMed ID: 10480617
[TBL] [Abstract][Full Text] [Related]
17. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
Miyazaki K; Nagai R; Horiuchi S
J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
[TBL] [Abstract][Full Text] [Related]
18. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.
Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515
[TBL] [Abstract][Full Text] [Related]
19. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
Voziyan PA; Khalifah RG; Thibaudeau C; Yildiz A; Jacob J; Serianni AS; Hudson BG
J Biol Chem; 2003 Nov; 278(47):46616-24. PubMed ID: 12975371
[TBL] [Abstract][Full Text] [Related]
20. Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite.
Sakasai-Sakai A; Takata T; Suzuki H; Maruyama I; Motomiya Y; Takeuchi M
Sci Rep; 2019 Jul; 9(1):10194. PubMed ID: 31308400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
